Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study was aimed to investigate long-term survivals and toxicities of early-stage nasopharyngeal carcinoma (NPC) in endemic area, evaluating the role of chemotherapy in stage II patients. Materials and methods: Totally 187 patients with newly diagnosed NPC and restaged American Joint Committee on Cancer/International Union Against Cancer 8th T1-2N0-1M0 were retrospectively recruited. All received intensity-modulated radiotherapy (IMRT)±chemotherapy (CT) from 2001 to 2010. Results: With 15.7-year median follow-up, 10-year locoregional recurrence-free survival, distant metastasis-free survival (DMFS), disease-specific survival (DSS), and overall survival (OS) were 93.3%, 93.5%, 92.9% and 88.2%, respectively. Multivariable analyses showed cervical lymph nodes positive and pre-treatment prognostic nutritional index ≥ 52.0 could independently predict DMFS (p=0.036 and p=0.011), DSS (p=0.014 and p=0.026), and OS (p=0.002 and p < 0.001); Charlson comorbidity index < 3 points could predict DSS (p=0.011); age > 45 years (p=0.002) and pre-treatment lactate dehydrogenase ≥ 240 U/L (p < 0.001) predicted OS. No grade 4 late toxicity happened; grade 3 late toxicities included subcutaneous fibrosis (4.3%), deafness or otitis (4.8%), skin dystrophy (2.1%), and xerostomia (1.1%). No differences on survivals were shown between IMRT+CT vs. IMRT alone in stage II patients, even in T2N1M0 (p > 0.05). Unsurprising, patients in IMRT+CT had more acute gastrointestinal reaction, myelosuppression, mucositis, late ear toxicity, and cranial nerve injury (all p < 0.05) than IMRT alone group. Conclusion: Superior tumor control and satisfying long-term outcomes could be achieved with IMRT in early-stage NPC with mild late toxicities. As CT would bring more toxicities, it should be carefully performed to stage II patients.
Abstract
Purpose: This study was aimed to investigate long-term survivals and toxicities of early-stage nasopharyngeal carcinoma (NPC) in endemic area, evaluating the role of chemotherapy in stage II patients. Materials and methods: Totally 187 patients with newly diagnosed NPC and restaged American Joint Committee on Cancer/International Union Against Cancer 8th T1-2N0-1M0 were retrospectively recruited. All received intensity-modulated radiotherapy (IMRT)±chemotherapy (CT) from 2001 to 2010. Results: With 15.7-year median follow-up, 10-year locoregional recurrence-free survival, distant metastasis-free survival (DMFS), disease-specific survival (DSS), and overall survival (OS) were 93.3%, 93.5%, 92.9% and 88.2%, respectively. Multivariable analyses showed cervical lymph nodes positive and pre-treatment prognostic nutritional index ≥ 52.0 could independently predict DMFS (p=0.036 and p=0.011), DSS (p=0.014 and p=0.026), and OS (p=0.002 and p < 0.001); Charlson comorbidity index < 3 points could predict DSS (p=0.011); age > 45 years (p=0.002) and pre-treatment lactate dehydrogenase ≥ 240 U/L (p < 0.001) predicted OS. No grade 4 late toxicity happened; grade 3 late toxicities included subcutaneous fibrosis (4.3%), deafness or otitis (4.8%), skin dystrophy (2.1%), and xerostomia (1.1%). No differences on survivals were shown between IMRT+CT vs. IMRT alone in stage II patients, even in T2N1M0 (p > 0.05). Unsurprising, patients in IMRT+CT had more acute gastrointestinal reaction, myelosuppression, mucositis, late ear toxicity, and cranial nerve injury (all p < 0.05) than IMRT alone group. Conclusion: Superior tumor control and satisfying long-term outcomes could be achieved with IMRT in early-stage NPC with mild late toxicities. As CT would bring more toxicities, it should be carefully performed to stage II patients.
참고문헌 (26)
- Wei KR, "Nasopharyngeal carcinoma incidence and mortality in China, 2013", Chin J Cancer, 36, pp.90~ (2017)
- O’Sullivan B, "Members of the IMRT Indications Expert Panel. Intensity-modulated radiotherapy in the treatment of head and neck cancer", Clin Oncol (R Coll Radiol), 24, pp.474~487 (2012)
- Peng G, "A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma", Radiother Oncol, 104, pp.286~293 (2012)
- Chua DT, "Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma : Subgroup analysis of two Phase III trials", Int J Radiat Oncol Biol Phys, 65, pp.1300~1306 (2006)
- Xiao WW, "Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 74, pp.1070~1076 (2009)
- Song CH, "Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma", Laryngoscope, 118, pp.663~670 (2008)
- Su SF, "Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone", Int J Radiat Oncol Biol Phys, 82, pp.327~333 (2012)
- Amin MB, "AJCC cancer staging manual" (2017), Springer
- Luo S, "Clinical outcomes for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in nonendemic region of China", Head Neck, 36, pp.841~847 (2014)
- Ding XC, "Ten-year outcomes of intensity-modulated radiotherapy(IMRT)combine with chemotherapy versus IMRT alone for stage II nasopharyngeal carcinoma in the real-world study(RWD)", Cancer Manag Res, 11, pp.8893~8903 (2019)
- Huang X, "Adding concurrent chemotherapy to intensity-modulated radiotherapy does not improve treatment outcomes for stage II nasopharyngeal carcinoma : a phase 2 multicenter clinical trial", Front Oncol, 10, pp.1314~ (2020)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Huang Y, "The impact of comorbidity on overall survival in elderly naso pharyngeal carcinoma patients : a National Cancer Data Base analysis", Cancer Med, 7, pp.1093~1101 (2018)
- Miao J, "Reprint of long-term survival and late toxicities of elderly nasopharyngeal carcinoma(NPC)patients treated by high-total-and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy", Oral Oncol, 90, pp.126~133 (2019)
- Ikeya T, "Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer", J Cancer Res Clin Oncol, 141, pp.307~313 (2015)
- Miao J, "The value of the prognostic nutritional index(PNI)in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma(NPC)patients receiving intensity-modulated radiotherapy(IMRT)with or without chemotherapy", J Cancer Res Clin Oncol, 143, pp.1263~1273 (2017)
- Hong S, "The prognostic nutritional index(PNI)predicts overall survival of small-cell lung cancer patients", Tumour Biol, 36, pp.3389~3397 (2015)
- Hofbauer SL, "The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma", Urol Oncol, 33, pp.68~ (2015)
- Jiang N, "Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer", World J Gastroenterol, 20, pp.10537~10544 (2014)
- Cox JD, "Toxicity criteria of the Radiation Therapy Oncology Group(RTOG)and the European Organization for Research and Treatment of Cancer(EORTC)", Int J Radiat Oncol Biol Phys, 31, pp.1341~1346 (1995)
- Miao J, "A prospective 10-year observational study of reduction of radiation therapy clinical target volume and dose in early-stage nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 107, pp.672~682 (2020)
- Chen QY, "Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma : phase III randomized trial", J Natl Cancer Inst, 103, pp.1761~1770 (2011)
- Aftab O, "Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma", Radiat Oncol, 15, pp.66~ (2020)
- Xu T, "Omission of chemotherapy in early stage nasopharyngeal carcinoma treated with IMRT : a paired cohort study", Medicine(Baltimore), 94, pp.e1457~ (2015)
- Xu C, "Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy : a propensity score-matched analysis", Oral Oncol, 78, pp.37~45 (2018)
- Xu C, "Chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma : a systemic review and meta-analysis of 2138 patients", J Cancer, 8, pp.287~297 (2017)